Cytotoxic flavonoids from the leaves of Cryptocarya chinensis. 2010

Tsung-Hsien Chou, and Jih-Jung Chen, and Shiow-Ju Lee, and Michael Y Chiang, and Cheng-Wei Yang, and Ih-Sheng Chen
Graduate Institute of Pharmaceutical Sciences, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan 807, Republic of China.

Bioassay-guided fractionation led to the isolation of six new tetrahydroflavanones, cryptochinones A-F (1-6), from the neutral CHCl(3) fraction of Cryptocarya chinensis leaves, together with 14 known compounds (7-20). The structures of these new compounds were determined through spectroscopic analyses, including 2D-NMR, MS, CD, and X-ray crystallographic analysis. Among the isolates, infectocaryone (7) showed cytotoxic activities with IC(50) values of 11.0 and 3.7 μM against NCI-H460 and SF-268 cell lines, respectively, and cryptocaryanone A (9) showed cytotoxic activities with IC(50) values of 5.1, 4.3, and 5.0 μM against MCF-7, NCI-H460, and SF-268 cell lines, respectively.

UI MeSH Term Description Entries
D010946 Plants, Medicinal Plants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals. Herbs, Medicinal,Medicinal Herbs,Healing Plants,Medicinal Plants,Pharmaceutical Plants,Healing Plant,Herb, Medicinal,Medicinal Herb,Medicinal Plant,Pharmaceutical Plant,Plant, Healing,Plant, Medicinal,Plant, Pharmaceutical,Plants, Healing,Plants, Pharmaceutical
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D005260 Female Females
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D018515 Plant Leaves Expanded structures, usually green, of vascular plants, characteristically consisting of a bladelike expansion attached to a stem, and functioning as the principal organ of photosynthesis and transpiration. (American Heritage Dictionary, 2d ed) Plant Leaf,Leaf, Plant,Leave, Plant,Leaves, Plant,Plant Leave
D031369 Cryptocarya A plant genus of the family LAURACEAE. Members contain cryptofolione, caryachine, grandisin and other compounds. Some PEUMUS species have been reclassified as CRYPTOCARYA. Cryptocaryas

Related Publications

Tsung-Hsien Chou, and Jih-Jung Chen, and Shiow-Ju Lee, and Michael Y Chiang, and Cheng-Wei Yang, and Ih-Sheng Chen
October 2001, Chemical & pharmaceutical bulletin,
Tsung-Hsien Chou, and Jih-Jung Chen, and Shiow-Ju Lee, and Michael Y Chiang, and Cheng-Wei Yang, and Ih-Sheng Chen
July 2014, Planta medica,
Tsung-Hsien Chou, and Jih-Jung Chen, and Shiow-Ju Lee, and Michael Y Chiang, and Cheng-Wei Yang, and Ih-Sheng Chen
May 2004, Journal of natural products,
Tsung-Hsien Chou, and Jih-Jung Chen, and Shiow-Ju Lee, and Michael Y Chiang, and Cheng-Wei Yang, and Ih-Sheng Chen
June 2012, Natural product communications,
Tsung-Hsien Chou, and Jih-Jung Chen, and Shiow-Ju Lee, and Michael Y Chiang, and Cheng-Wei Yang, and Ih-Sheng Chen
April 2012, Phytochemistry,
Tsung-Hsien Chou, and Jih-Jung Chen, and Shiow-Ju Lee, and Michael Y Chiang, and Cheng-Wei Yang, and Ih-Sheng Chen
April 2024, Natural product research,
Tsung-Hsien Chou, and Jih-Jung Chen, and Shiow-Ju Lee, and Michael Y Chiang, and Cheng-Wei Yang, and Ih-Sheng Chen
June 2013, Phytochemistry,
Tsung-Hsien Chou, and Jih-Jung Chen, and Shiow-Ju Lee, and Michael Y Chiang, and Cheng-Wei Yang, and Ih-Sheng Chen
March 2021, Natural product research,
Tsung-Hsien Chou, and Jih-Jung Chen, and Shiow-Ju Lee, and Michael Y Chiang, and Cheng-Wei Yang, and Ih-Sheng Chen
February 2021, Molecules (Basel, Switzerland),
Tsung-Hsien Chou, and Jih-Jung Chen, and Shiow-Ju Lee, and Michael Y Chiang, and Cheng-Wei Yang, and Ih-Sheng Chen
October 2005, Planta medica,
Copied contents to your clipboard!